Alembic Pharmaceuticals on Tuesday announced that its wholly owned subsidiary, Aleor Dermaceuticals has received final approval from the USFDA lidocaine and prilocaine cream.
India adds 796 new cases in the last 24 hours. Daily positivity rate stands at 0.20%. Weekly Positivity Rate at 0.24%. Indias Active caseload currently stands at 10,889. Active cases stand at 0.03%. Recovery Rate currently stands at 98.76% with 946 recoveries in the last 24 hours taking the total recoveries to 4,25,04,329. 79.45 crore tests were conducted so far; 4,06,251 tests conducted in the […]
The PSU clients, against whom the Company has received the awards, have preferred to appeal the same, which are presently at various levels of hearing at the Courts.
In the digital era, Aurionpro’s journey has gained significant momentum, with the innovation of new technologies.
Gufic Biosciences soared 10.65% to Rs 274.25 on securing permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation to make Isavuconazonium Sulfate API and finished formulation Isavuconazole injection.
The company will be responsible for supplying NBC HAVERSACK MK-11.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
